Indications for the Boston KPro include multiple graft failures, Stevens-Johnson syndrome (SJS) [13] , ocular cicatricial pemphigoid (OCP), other autoimmune diseases [14] , ocular burns (acid and alkali) [15] [16] and other conditions with poor prognosis with traditional PKP.

Jun 1, 2017 · It is implanted as a treatment for many severe, recalcitrant corneal disorders that are not amenable to traditional corneal transplantation such as penetrating ker­atoplasty (PK).

The Boston KPro is a treatment option for corneal disorders not amenable to standard penetrating keratoplasty (corneal transplantation) or corneal transplant.

Mar 10, 2023 · Permanent keratoprosthesis (KPro) has restored vision in many patients with anterior segment diseases, however, it may lead to vision-threatening posterior segment complications. In this article, we’ll review the retinal complications that can occur with these devices and how to manage them. Background. Figure 1.

Apr 1, 2021 · Keratoprosthesis (KPro) is ideal for corneas that have extensive areas of vascularization, and/or have had multiple previous transplant failures, limbal stem cell deficiencies with or without cicatrizing conjunctivitis in the setting of …

Apr 8, 2016 · Keratoprosthesis implantation is a procedure that involves full-thickness removal of the cornea and replacement by an artificial cornea. The Boston Type I Keratoprosthesis is currently the most commonly used keratoprosthesis device in the US.

Today, the Boston KPro is the most commonly used corneal prosthesis in the world with more than 11,000 implantations to date in 66 countries by 598 surgeons. In 2014, KPro received European Conformity (CE) mark approval, making the device reimbursable across the European market and, thus, accessible to many more people.

Advances in postoperative care have greatly improved the clinical success of the Boston KPro. Common complications such as inflammation and infection are significantly lower with today’s prophylactic drug regimens. Innovative devices have also …

To review the published literature on safety and outcomes of the Boston type I keratoprosthesis (BI-KPro) for the surgical treatment of corneal opacification not amenable to human cadaveric corneal transplantation.

The Boston Type 2 Keratoprosthesis (KPro) is an artificial device used to replace the cornea in the setting of diseases with severe, recurrent scarring in which other types of corneal transplants are not a viable option.